06/04/2026
Hot off the press! ๐๏ธ
We are thrilled to share that our treatment outcomes have been published in a peer-reviewed journal!
A few highlights:
๐ง Neurobehavioral Symptom Inventory total score decreased by an average of 15.6 points (41%) by the end of the three-week program
๐ญ Scores on Addenbrooke's Cognitive Examination-III improved by 6.8 points
๐ถโโ๏ธ Gait speed and vestibular measures showed significant improvements
โก The proportion of patients screening at or above a commonly used PTSD threshold on the PCL-5 declined from 51% at intake to 20% at discharge
๐ฆ Higher baseline PTSD symptom scores were associated with higher neurobehavioral symptom scores across time points
Ultimately, our findings were consistent with multidomain benefits of intensive, interdisciplinary neuropsychiatric rehabilitation in the mild/moderate TBI population. We're excited to continue this work as part of the VICTORY clinical trial!
PubMed link: https://pubmed.ncbi.nlm.nih.gov/42168808/